American Journal of Physiology-Gastrointestinal and Liver Physiology · 2016 · 38 citations · 35 references
Veterinary MedicineImmunologyPharmacologyImmunoregulationInflammationInnate ImmunityCytokine BiologyGastrointestinal InflammationInflammatory Bowel DiseaseInflammatory Cell ResponsesInflammatory Cell SignalingInflammatory SignalingAcute Inflammatory ResponseBile Acid PharmacologyBile Acid ToxicityInflammatory Bowel Disease PathogenesisInflammatory Bowel Disease PathophysiologyInflammatory Bowel Disease TherapyProinflammatory Cytokine ModulationProinflammatory Mediators
Monocytes are critical to the pathogenesis of inflammatory bowel disease (IBD) as they infiltrate the mucosa and release cytokines that drive the inflammatory response. Ursodeoxycholic acid (UDCA), a naturally occurring bile acid with anti-inflammatory actions, has been proposed as a potential new therapy for IBD. However, its effects on monocyte function are not yet known. Primary monocytes from healthy volunteers or cultured U937 monocytes were treated with either the proinflammatory cytokine, TNFα (5 ng/ml) or the bacterial endotoxin, lipopolysaccharide (LPS; 1 μg/ml) for 24 h, in the absence or presence of UDCA (25-100 μM). IL-8 release into the supernatant was measured by ELISA. mRNA levels were quantified by qPCR and changes in cell signaling proteins were determined by Western blotting. Toxicity was assessed by measuring lactate dehydrogenase (LDH) release. UDCA treatment significantly attenuated TNFα-, but not LPS-driven, release of IL-8 from both primary and cultured monocytes. UDCA inhibition of TNFα-driven responses was associated with reduced IL-8 mRNA expression. Both TNFα and LPS stimulated NFκB activation in monocytes, while IL-8 release in response to both cytokines was attenuated by an NFκB inhibitor, BMS-345541. Interestingly, UDCA inhibited TNFα-, but not LPS-stimulated, NFκB activation. Finally, TNFα, but not LPS, induced phosphorylation of TNF receptor associated factor (TRAF2), while UDCA cotreatment attenuated this response. We conclude that UDCA specifically inhibits TNFα-induced IL-8 release from monocytes by inhibiting TRAF2 activation. Since such actions would serve to dampen mucosal immune responses in vivo, our data support the therapeutic potential of UDCA for IBD.
35
A G Protein-coupled Receptor Responsive to Bile Acids
Yuji Kawamata, Ryo Fujii, Masaki Hosoya et al. · Journal of Biological Chemistry · 2003 · 1.6K citations · Full text
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
Henri Duboc, Sylvie Rajca, Dominique Rainteau et al. · Gut · 2012 · 922 citations
The Distinct Roles of TRAF2 and RIP in IKK Activation by TNF-R1
Anne Devin, Amy Cook, Yong Lin et al. · Immunity · 2000 · 430 citations · Full text
Erin G. Schuetz, Stephen C. Strom, Kazuto Yasuda et al. · Journal of Biological Chemistry · 2001 · 391 citations · Full text
Cecília M. P. Rodrigues, Guangsheng Fan, Phillip Wong et al. · Molecular Medicine · 1998 · 332 citations · Full text